The statement is largely accurate regarding the key entities and the financial amount involved, but it mischaracterizes the nature of the transaction.1. **Participants and Funding:** Multiple high-authority, primary sources confirm that Cypherpunk (formerly Leap Therapeutics) received funding from Winklevoss Capital, the investment firm of the Winklevoss Brothers. The company's own press release and news reports from The Block and CoinDesk all corroborate this relationship.2. **Financial Amount:** The figure of ¥9.1 billion is directly supported by a primary source, the law firm Morgan Lewis, which advised on the deal. Their press release explicitly states they advised Cypherpunk on a "$58.88 million (~¥9.1 billion) private placement led by Winklevoss Capital." This provides strong evidence for the specific amount mentioned in the claim.3. **Purpose of Transaction (The Inaccuracy):** The key inaccuracy lies in the phrase "for the acquisition of Zcash." This wording is ambiguous and could imply a corporate takeover of the Zcash project or its parent company. The provided sources consistently clarify that the funds were used to establish a "Zcash Treasury." This means Cypherpunk acquired a large amount of the Zcash cryptocurrency (ZEC) to hold as a reserve asset on its corporate balance sheet, not to buy out the entire project. The CoinDesk report explicitly clarifies the transaction was a "treasury investment, not an acquisition of the Zcash project itself."In conclusion, the statement correctly identifies the parties and the amount of money involved, which are the core factual claims. However, it uses imprecise language that misrepresents the strategic goal of the transaction. Because the main financial and personnel facts are correct, the statement is assessed as "likely_true," but the 15% false probability accounts for the significant mischaracterization of the deal's purpose. The confidence level is high due to the consistency and high authority of the supporting primary sources.